mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.04 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.04 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.04 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.04 |